about
Emerging roles for platelets as immune and inflammatory cellsRacial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376cMeta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system.Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets.Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis.Slowed decay of mRNAs enhances platelet specific translationBlood born miRNAs signatures that can serve as disease specific biomarkers are not significantly affected by overall fitness and exercisePlatelets direct monocyte differentiation into epithelioid-like multinucleated giant foam cells with suppressive capacity upon mycobacterial stimulation.The repertoire and features of human platelet microRNAs.The regulatory loop of COMP1 and HNF-4-miR-150-p27 in various signaling pathways.Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function.Plasma miR-122 and miR-3149 Potentially Novel Biomarkers for Acute Coronary Syndrome.Grazing Affects Exosomal Circulating MicroRNAs in Cattle.Platelets and platelet-like particles mediate intercellular RNA transfer.Platelet mRNA: the meaning behind the messageThe independent contribution of miRNAs to the missing heritability in CYP3A4/5 functionality and the metabolism of atorvastatin.Personalized medicine in thrombosis: back to the future.Hyperglycaemia-induced reciprocal changes in miR-30c and PAI-1 expression in platelets.MicroRNA deregulation in polycythemia vera and essential thrombocythemia patients.MicroRNAs 10a and 10b Regulate the Expression of Human Platelet Glycoprotein Ibα for Normal Megakaryopoiesis.miR-125b modulates megakaryocyte maturation by targeting the cell-cycle inhibitor p19INK4D.MicroRNAs in myeloproliferative neoplasms.The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancerPlatelet microRNAs: From platelet biology to possible disease biomarkers and therapeutic targets.MicroRNAs in platelet production and activation.Role of platelets in inflammation and cancer: novel therapeutic strategies.Antiplatelet therapy: targeting the TxA2 pathway.Transfection of Kasumi-1 cells with a new type of polymer carriers loaded with miR-155 and antago-miR-155.Extracellular vesicles and atherosclerotic disease.Regulation of the genetic code in megakaryocytes and platelets.Peculiarities of studying the effects of pathogen reduction technologies on platelets.Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes.Platelet RNA signatures for the detection of cancer.Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice.The platelets' perspective to pathogen reduction technologies.miR-941 as a promising biomarker for acute coronary syndrome.Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor.Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease.miRNAs can increase the efficiency of ex vivo platelet generation.
P2860
Q27016553-767F03AC-A237-4926-80B4-92A44FBC8201Q30558959-03E84C2D-654F-482C-AE5F-9F618FA80696Q33397396-674987DA-9676-41BB-8D5C-7542E17CFAD8Q33407110-4C216ECD-184F-4B57-8828-CDC89163EED9Q33429232-8493FA4E-23DB-448B-94D5-1C4D80CF62DDQ33432575-B388854B-3610-498D-9719-9E1AE7EB4D22Q33615612-390886CB-887B-44DC-834F-A99C126ABC20Q33882686-3BA6A749-2409-4782-BC62-BD0DFF0FE750Q34471478-623B55FB-486E-42E0-A376-877901812114Q34506593-D3BDF164-0EF5-449B-B73C-067466417F1EQ34584197-DC88C664-E118-49EC-AE68-B6D6477F06D4Q35190154-5DA91D71-461F-4AD5-8964-C228283ECE86Q35560920-A5A6B221-5179-4408-9981-7460FCEAE218Q35998011-6FCDF8E9-D0AA-469D-8F1B-3B46E803F3C5Q36058568-8BF3B8C8-D99A-4700-B1BA-39C1DEB1DBA5Q36897250-97257FEC-590F-462D-8818-1C88E1824CE8Q36925256-5C4B23C0-3AA9-4001-AA06-CE641CA9EFB1Q36965849-3DDE9B32-1CF3-4DAE-B224-C6A0B90C0321Q37397301-371E2726-8420-4171-AD22-167E4892BF82Q37408774-D79AD64E-20B4-41DC-A2DC-D14CFF6FECC1Q37465554-748B75E3-5ED2-43AF-B038-54E766025139Q37465842-F96ADD03-A084-4EB7-9B61-96E50FCD73EEQ37529812-00B5C778-FA2B-4264-A1A9-61FBA14DC8EBQ37997552-7EDCE326-6425-4F44-AB71-BDC739A164BAQ38044999-DF56F39E-3545-4DB0-861C-48327F1B1F0CQ38117746-C90D7B74-69C0-48B0-85E0-0F97E3C3B6A7Q38151957-B0B6B51F-A859-49A0-9148-546B4406A0FEQ38172461-01686B26-EA04-4D34-B353-5E73BBF6DA44Q38316665-9B639CA4-3A73-4664-B6FF-7BAD876A90A9Q38430673-88BD3DD0-5A21-4DD7-8546-43B698FF6D4FQ38543301-FF5D2E66-BC25-4A80-B910-ECA77D32DF76Q38812483-5B7C6627-5222-47D6-948D-E100D5C8D0F5Q38893517-1EED65FF-C478-422C-8C27-7C92C2831FDAQ39417299-B1D73D42-5704-456C-906D-E2F0E9E3A678Q39571357-8E8DF043-DFC4-4123-9AD4-C8E7A19EE867Q40273685-D2852BD4-7DF4-43BF-BDE1-3F3BB5F28218Q41498547-4464C0A6-6106-4382-941A-0B039F16A326Q42246588-C6FADD52-A42C-45ED-8BA8-484AD0DA7ED7Q42581726-0C783825-F6B1-4DF3-A54A-F763D89BA769Q44209682-BE3191F4-99A0-43AA-836D-C33D9DF32389
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
MicroRNAs in platelet production and activation
@ast
MicroRNAs in platelet production and activation
@en
MicroRNAs in platelet production and activation
@nl
type
label
MicroRNAs in platelet production and activation
@ast
MicroRNAs in platelet production and activation
@en
MicroRNAs in platelet production and activation
@nl
prefLabel
MicroRNAs in platelet production and activation
@ast
MicroRNAs in platelet production and activation
@en
MicroRNAs in platelet production and activation
@nl
P2860
P3181
P1433
P1476
MicroRNAs in platelet production and activation
@en
P2093
Paul F Bray
P248
P2860
P304
P3181
P356
10.1182/BLOOD-2011-01-292011
P407
P577
2011-03-01T00:00:00Z